Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-04-16
1996-01-09
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 14, 514 15, 514 16, 514 17, A61K 3836, A61K 3808
Patent
active
054829232
ABSTRACT:
Circulating heparin in a mammal may be neutralized without substantial depletion of platelets or leukocytes by administering to the mammal a heparin neutralizing amount of a purified heparin binding fragment of PF4 or of recombinant PF4.
REFERENCES:
patent: 3985618 (1976-10-01), Innerfield
patent: 4702908 (1987-10-01), Thorbecke et al.
patent: 4844895 (1989-07-01), Thorbecke et al.
patent: 4861757 (1989-08-01), Antoniades et al.
Lane et al J.B.C. 261 (9) pp. 3980-3986 1986.
Brindley et al., "Stimulation of Histamine Release from Human Basophils by Human Platelet Factor 4", J. Clin. Invest. vol. 72, Oct. 1983, 1218-1223.
Castaneda, "Must Heparin Be Neutralized following Open Heart Operations?" Journal of Thoracic and Cardiovascular Surgery, vol. 52, No. 5, Nov. 1966, p. 716.
Cavarocchi et al., "Evidence for Complement Activation by Protamine-Heparin Interaction after Cardiopulmonary Bypass", Surgery, Sep. 1985, p. 526.
Cella et al., "Human Platelet Factor 4 and Protamine Sulfate Interaction with Glycosaminoglycans in the Rabbit", European Journal of Clinical Investigation, 17:548-554 (1987).
Colman, "Humoral Mediators of Catastrophic Reactions Associated with Protamine Neutralization", The Journal of Anesthesiology, vol. 66, No. 5, May 1987, p. 595.
Dawes et al., "The Release, Distribution and Clearance of Human Beta Thromboglobulin and Platelet Factor 4", Thrombosis Research, vol. 12, No. 5, pp. 851-861.
Deuel et al., "Platelet Factor 4 is Chemotactic for Neutrophil and Monocytes", Proc. Natl. Acad. Sci. U.S.A., vol. 78, No. 7, pp. 4584-4587, Jul. 1981.
Fehr et al., "In Vivo Complement Activation by Polyanion-Polcation Complexes: Evidence that C5a is Generated Intravascularly During Heparin-Protamine Interaction", Clinical Immunology and Immunopathology, 29, 7-14 (1983).
Flicker et al., "Platelet Factor Release following Heparin Administration and during Extracorporeal Circulation", Trans. Am. Soc. Artif. Intern. Organs, 1982, p. 431.
Handin et al., "Purification and Binding Properties of Human Platelet Factor 4", The Journal of Biological Chemistry, vol. 251, No. 14, pp. 4273-4282, 1976.
Harker, "Mechanism of Abnormal Bleeding in Patients Undergoing Cardiopulmonary Bypass: Acquired Transient Platelet Dysfunction Associated with Selective Alpha Granule Release", Blood, vol. 56, No. 4, Oct. 1980, p. 824.
Hermodson et al., "Isolation, Crystallization and Primary Amino Acid Sequence of Human Platelet Factor 4" (1979) J. Biol. Chem., 252, 6276-6279.
Holloway et al., "Decreased Platelet Number and Function and Increased Fibrinolysis contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients", Thrombosis and Haemostasis, 59(1) 62-67 (1988).
Holt et al., "Biochemistry of Alpha Granule Proteins", Sem. in Hemotology, vol. 22, No. 2, (Apr. 1985), pp. 151-163.
Horrow, "Protamine: A Necessary Evil?" in Effective Hemostatis in Cardiac Surgery, Eds. Ellison & Jobes, in press.
Horrow, "Protamine: A Review of its Toxicity", Anest. and Analg. 1985, 64:348-61.
Horrow, "Protamine Allergy" Journal of Cardiothoracic Anesthesia, vol. 2, No. 2, (Apr. 1988), pp. 225-242.
Just-Viera et al., "Acute Reaction to Protamine", The American Surgeon, Jan. 1984, p. 52.
Lakin et al., "Anaphylaxis to Protamine Sulphate Mediated by Complement Dependent IgG Antibody", J. of Allergy and Clinical Immunology, vol. 61, No. 1, Jan. 1978, pp. 102-107.
Lane et al., "Anticoagulant Activities of Heparin Oligosaccharides and their Neutralization by Platelet Factor 4", Biochem. J., (1984) 218, 725-732.
Letters to the New England Journal of Medicine concerning Weiss et al., "Life Threatening Reactions to Intravenous Protamine", vol. 321, No. 24, p. 1684, Dec. 1989.
Levine et al., "Human Platelet Factor 4: Purification and Characterization by Affinity Chromatography", The Journal of Biological Chemistry, vol. 251 No. 2, pp. 324-328, 1976.
Maione et al., "Inhibition of Angiogenesis by Recombinant Human Platelet Factor 4 and Related Peptides", Science, vol. 247, 5 Jan. 1990, p. 77.
Michalski, "Neutralization of Heparin in Plasma by Platelet Factor 4 and Protamine Sulphate", British Journal of Haematology, 1978, 38:561-571.
Morel et al., "Acute Pulmonary Vascoconstriction and Thromboxane Release during Protamine Reversal of Heparin Anticoagulation in Awake Sheep: Evidence for the Role of Reactive Oxygen Metabolytes following Nonimmunological Compliment Activation", Circulation Research, vol. 62, No. 5, May 1988, p. 905.
Rao et al., "Effect of Heparin on the In Vivo Release and Clearance of Human Platelet Factor 4", Blood, vol. 61, No. 6, (Jun. 1983), pp. 1208-1214.
Rent et al., "Complement Activation by Interaction of Polyanions and Polycations 1. Heparin-protamine consumptin of Compliment", The Journal of Immunology. 1975, p. 120.
Rucinski et al., "Clearance of Human Platelet Factor 4 by Liver and Kidney: It's Alternation by Heparin", American Journal of Physiology, Oct. 1986, vol. 251, No. 4, p. H800.
Shanberge et al. "Heparin-Protamine Complexes in the Production of Heparin Rebound and Other Complications of Extra Corporeal Bypass Procedures", American Journal of Clinical Pathology, vol. 87, p. 210, 1987.
Shanberge et al., "Interrelationship of Protamine and Platelet Factor 4 in the Neutralization of Heparin", Thrombosis Research, 46:89-100, 1987.
Taylor et al., "Comparison of the Cardiovascular Effects of Intravenous and Intra-aortic Protamine in the Conscious and Anesthetized Dog", Ann Thorac Surg, 42:22-26, Jul. 1986.
Walker et al., "Successful Cardiopulmonary Bypass in Diabetics with Anaphylactoid Reactions to Protamine", British Heart Journal, 1984, 52:112-4.
Walz et al., "In Vivo Studies on the Binding of Heparin and its Fractions with Platelet Factor 4", Seminars in Thrombosis and Hemostasis, vol. 11, No. 1, 1985, p. 40.
Weiss et al., "Association of Protamine IgE and IgG Antibodies with Light Life Threatening Reactions to Intravenous Protamine", The New England Journal of Medicine, vol. 320, No. 14, p. 886, 1989.
Cowan et al., Biochem. J., 234:485-488 (1986).
Lane et al., J. Biol. Chem., 261(9):3980-3986 (1986).
Repligen Corporation
Schmickel David B.
Schwartz Richard A.
LandOfFree
Heparin neutralization with platelet factor 4 fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparin neutralization with platelet factor 4 fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin neutralization with platelet factor 4 fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1303167